| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999034823A3 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 09/16/1999 | WO1998056759A3 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/16/1999 | CA2659664A1 Improved radiation therapy methods |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323456A1 Benzofurylpyrone derivatives |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2322824A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | CA2322743A1 Fibrinogen receptor antagonists |
| 09/16/1999 | CA2322741A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322508A1 Modified factor viii |
| 09/16/1999 | CA2320936A1 Supercritical conditioned gas mixture containing co2, no and optionally a neutral gas |
| 09/15/1999 | EP0941355A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |
| 09/15/1999 | EP0941242A2 Secreted proteins and polynucleotides encoding them |
| 09/15/1999 | EP0941218A1 Antithrombotic organic nitrates |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941103A1 Pharmaceutical composition for treatment of diabetes |
| 09/15/1999 | EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 09/15/1999 | EP0759899B1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 09/15/1999 | EP0656001B1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 09/15/1999 | CN1228785A Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 09/15/1999 | CN1228783A Thrombin inhibitor |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228765A New amidino derivatives and their use as thrombin inhibitors |
| 09/15/1999 | CN1228701A Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis |
| 09/15/1999 | CN1228698A Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine derivative and HMG-CoA-reductase inhibitor |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228314A Drug for curing 'subdermal implantation', 'drug abortion' postoperative endometrorrhagia and its preparing method |
| 09/14/1999 | US5952482 Production of hemoglobin having a δ-like globin |
| 09/14/1999 | US5952369 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/14/1999 | US5952226 Hypoxia responsive EPO producing cells |
| 09/14/1999 | US5951981 Thrombolytic agents with antithrombotic activity |
| 09/10/1999 | WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999032477B1 Ortho-anthranilamide derivatives as anti-coagulants |
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
| 09/08/1999 | EP0939815A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
| 09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939806A1 Fanconi gene 1 |
| 09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
| 09/08/1999 | EP0939767A1 Modified factor viii |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939757A1 Novel integrin receptor antagonists |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939644A1 Enhanced stimulation of erythropoiesis |
| 09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 09/08/1999 | EP0669834B1 Use of topically applied factor xiii for inhibiting hemorrhage |
| 09/08/1999 | CN1228092A Purine derivatives and their use as anti-coagulants |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948759 Factor VII fragment 82-128 and its use in blood-clotting disorders |
| 09/07/1999 | US5948752 Suppressory agents against hypercoagulation |
| 09/07/1999 | US5948609 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/07/1999 | US5948405 Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity |
| 09/07/1999 | CA2128795C A virus-safe blood coagulation factor xiii preparation |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/07/1999 | CA1340722C Pharmaceutical composition for the treatment of high blood pressure |
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043712A1 Method for producing a factor viii/von willebrand factor complex |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043648A1 Cyclic amino compounds |
| 09/02/1999 | WO1999043310A2 20-hete antagonists and agonists |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | DE19806853A1 Verfahren zur Herstellung von Polymeren aus N-Vinylverbindungen A process for preparing polymers of N-vinyl compounds |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938489A1 New phosphonates, process for preparing the same and medicaments |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | CN1227604A Multivarient IL-3 hematopoiesis fusion protein |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227553A Bicyclic pyrimidine derivatives and their use as anti-coagulants |
| 09/01/1999 | CN1227485A Treatment of hemoglobinopathy |
| 09/01/1999 | CN1227110A Hemostatic sterilizing agent |
| 09/01/1999 | CN1227107A External use hemostatic powder |
| 09/01/1999 | CN1044906C 3(2H)-pyridazinono derivatives, its preparing method and its composition |
| 08/31/1999 | US5945528 Efficient, simple process by forcing starch through high pressure precision disintegration valve causing homogenization |
| 08/31/1999 | US5945399 Administering to provide alleviation of adverse efects of or complications associated with the disease including mortality and complications or morbidities |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945275 Nematode-extracted anticoagulant protein |
| 08/31/1999 | US5945103 Process for producing thrombin |
| 08/31/1999 | US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/26/1999 | WO1999042501A2 Method for the production of polymers from n-vinyl compounds |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042475A1 Azole peptidomimetics as thrombin receptor antagonists |